Literature DB >> 7781690

Minor alkaloids of tobacco release [3H]dopamine from superfused rat striatal slices.

L P Dwoskin1, L Teng, S T Buxton, A Ravard, N Deo, P A Crooks.   

Abstract

In addition to S(-)-nicotine, several minor tobacco alkaloids ((+/-)-nornicotine, anabaseine, S(-)-anabasine, and S(-)-N-methylanabasine) are present in tobacco smoke. This study demonstrates that these alkaloids increase fractional 3H release in a concentration-dependent manner from rat striatal slices preloaded with [3H]dopamine, with desensitization of this response. The rank order of EC50 values was S(-)-nicotine (3.0 +/- 2.2 microM) > (+/-)-nornicotine (6.7 +/- 2.1 microM) > anabaseine (15.4 +/- 6.1 microM) = S(-)-N-methylanabasine (16.3 +/- 4.7 microM) = S(-)-anabasine (19.3 +/- 3.2 microM). The alkaloids did not modulate fractional 3H release evoked by electrical-field depolarization. Thus, minor tobacco alkaloids may contribute to the apparent neuroprotective effects of smoking in neurodegenerative diseases.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7781690     DOI: 10.1016/0014-2999(95)00077-x

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  8 in total

1.  A general procedure for the enantioselective synthesis of the minor tobacco alkaloids nornicotine, anabasine, and anatabine.

Authors:  Joshua T Ayers; Rui Xu; Linda P Dwoskin; Peter A Crooks
Journal:  AAPS J       Date:  2005-10-31       Impact factor: 4.009

2.  Differential effects of non-nicotine tobacco constituent compounds on nicotine self-administration in rats.

Authors:  Brandon J Hall; Corinne Wells; Cheyenne Allenby; Mung Yan Lin; Ian Hao; Lindsey Marshall; Jed E Rose; Edward D Levin
Journal:  Pharmacol Biochem Behav       Date:  2014-02-21       Impact factor: 3.533

3.  Smoke extracts and nicotine, but not tobacco extracts, potentiate firing and burst activity of ventral tegmental area dopaminergic neurons in mice.

Authors:  Fabio Marti; Ouafa Arib; Carole Morel; Virginie Dufresne; Uwe Maskos; Pierre-Jean Corringer; Renaud de Beaurepaire; Philippe Faure
Journal:  Neuropsychopharmacology       Date:  2011-06-29       Impact factor: 7.853

4.  Abuse liability assessment of an e-cigarette refill liquid using intracranial self-stimulation and self-administration models in rats.

Authors:  M G LeSage; M Staley; P Muelken; J R Smethells; I Stepanov; R I Vogel; P R Pentel; A C Harris
Journal:  Drug Alcohol Depend       Date:  2016-09-01       Impact factor: 4.492

5.  Targeting reward-relevant nicotinic receptors in the discovery of novel pharmacotherapeutic agents to treat tobacco dependence.

Authors:  Linda P Dwoskin; Marharyta Pivavarchyk; B Matthew Joyce; Nichole M Neugebauer; Guangrong Zheng; Zhenfa Zhang; Michael T Bardo; Peter A Crooks
Journal:  Nebr Symp Motiv       Date:  2009

Review 6.  Impact of tobacco regulation on animal research: new perspectives and opportunities.

Authors:  Eric C Donny; Tracy G Taylor; Mark G LeSage; Melissa Levin; Deanne M Buffalari; Danielle Joel; Alan F Sved
Journal:  Nicotine Tob Res       Date:  2012-09-04       Impact factor: 4.244

7.  A Pharmacological Comparison of Two Isomeric Nicotinic Receptor Agonists: The Marine Toxin Isoanatabine and the Tobacco Alkaloid Anatabine.

Authors:  Hong Xing; Sunil Keshwah; Anne Rouchaud; William R Kem
Journal:  Mar Drugs       Date:  2020-02-11       Impact factor: 5.118

8.  Differentiating the Neuropharmacological Properties of Nicotinic Acetylcholine Receptor-Activating Alkaloids.

Authors:  Omar Alijevic; Oihane Jaka; Ainhoa Alzualde; Diana Maradze; Wenhao Xia; Stefan Frentzel; Andrew N Gifford; Manuel C Peitsch; Julia Hoeng; Kyoko Koshibu
Journal:  Front Pharmacol       Date:  2022-03-22       Impact factor: 5.810

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.